Phase 4: the 1.7mg acceleration dose (34 units) The jump from 1.0mg to 1.7mg is the largest single escalation in the standard protocol, a 0.7mg increase compared to the 0.25mg and 0.5mg jumps earlier
Our complete semaglutide vs tirzepatide comparison guide covers this in detail, but here are the key differences in weight loss outcomes: Average Weight Loss Comparison Semaglutide (STEP-1 trial, 68 weeks): Average weight loss: 14.9% 69.1% lost 10% or more 50.5% lost 15% or more Tirzepatide (SURMOUNT-1 trial, 72 weeks at 15 mg dose): Average weight loss: 22.5% 89% lost 10% or more 78% lost 15% or more Tirzepatide shows higher average weight loss in clinical trials, though both medications demonstrate significant effectiveness
Injectable semaglutide is administered as a once-weekly subcutaneous injection, with a half-life of approximately one week
As a board-certified plastic surgeon, I often have open conversations with patients to set expectations about what happens to their bodies as they lose weight, and how to optimize losing fat instead of muscle using the GLP-1 Diet. The key to feeling your best and achieving lasting results isnt just the medicationits also about making smart nutritional choices to support your body along the way
This pattern of regain is consistent across trials of weight-loss medications in which participants were suddenly taken off the medication without a tapering schedule (where the dose is gradually reduced over time)
